FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

3886011000001107: Nadolol 40mg / Bendroflumethiazide 5mg tablets 28 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
21748101000001111 Nadolol 40mg / Bendroflumethiazide 5mg tablets 28 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
21748201000001116 Nadolol 40mg / Bendroflumethiazide 5mg tablets 28 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Nadolol 40mg / Bendroflumethiazide 5mg tablets 28 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Nadolol 40mg / Bendroflumethiazide 5mg tablets 28 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Nadolol 40mg / Bendroflumethiazide 5mg tablets 28 tablet Is pack of Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Nadolol 40mg / Bendroflumethiazide 5mg tablets 28 tablet Has active ingredient Nadolol false Inferred relationship Existential restriction modifier
Nadolol 40mg / Bendroflumethiazide 5mg tablets 28 tablet Has active ingredient Bendroflumethiazide false Inferred relationship Existential restriction modifier
Nadolol 40mg / Bendroflumethiazide 5mg tablets 28 tablet Has active ingredient Bendrofluazide - chemical false Inferred relationship Existential restriction modifier
Nadolol 40mg / Bendroflumethiazide 5mg tablets 28 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Nadolol 40mg / Bendroflumethiazide 5mg tablets 28 tablet VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Nadolol 40mg / Bendroflumethiazide 5mg tablets 28 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Nadolol 40mg / Bendroflumethiazide 5mg tablets 28 tablet Has VMP Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Nadolol 40mg / Bendroflumethiazide 5mg tablets 28 tablet Has specific active ingredient Nadolol true Inferred relationship Existential restriction modifier
Nadolol 40mg / Bendroflumethiazide 5mg tablets 28 tablet Has specific active ingredient Bendroflumethiazide true Inferred relationship Existential restriction modifier
Nadolol 40mg / Bendroflumethiazide 5mg tablets 28 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Corgaretic 40mg tablets (Sanofi-Synthelabo Ltd) 28 tablet 2 x 14 tablets Is a True Nadolol 40mg / Bendroflumethiazide 5mg tablets 28 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start